Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Event Logistics

- PMLiVE

AbbVie: New firm, new thinking

UK general manager Matt Regan talks to PME about creating an evolved culture from Abbott

EISAI

Eisai’s thyroid cancer drug Lenvima nears EU approval

Positive recommendation by the CHMP could see the orphan drug used in Europe within three months

Shire Basingstoke

Shire links with US hospital for rare disease research

Willwork with Cincinnati Children's Hospital Medical Centre novel therapies

Webinar: Capturing “in-the-moment” patient and physician insights

Utilising the benefits of mobile technology

Inizio

Webinar: Observational Research

Presenting a window on the world of your customer

Inizio

Webinar: The Brazil Conundrum

Conducting research in one of the world's largest pharma markets

Inizio

Webinar: Demand calibration: What’s inside the black box?

The process of demand calibration of preference share (down-weighting) is often a proprietary "black box" technique, which can mean that the client is unsure how the calibrated figure has been...

Inizio

UK Life Sciences Strategy - one year on

AstraZeneca joins Genomics England consortium

Combines with other pharma firms such as Illumina to utilise genetic data to create new medicines

- PMLiVE

Novo Nordisk will refile rejected diabetes duo in US

Danish firm hopes it will be second time lucky with key treatment

Free Thinking: Behavioural economics

Our Free Thinking white paper asks, does behavioural economic theory have a role to play in pharmaceutical market research?

Inizio

german flag

German pharma market to edge up to $65bn by 2020

Report finds that laws designed to curb drug prices will also slow down growth

Article: The Colombia Conundrum

Published in eye for pharma 30 January by Marc Yates

Inizio

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links